Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease
Steffen Bank, Mette Julsgaard, Osama Karim Abed, Johan Burisch, Jacob Broder Brodersen, Natalia Konstantinovich Pedersen, Anja Gouliaev, Rullah Ajan, Ditlev Nytoft Rasmussen, Camilla Honore Grauslund, Stine Roug, Julie Galsgaard, David Sprogoe Hoyer Finsen, Karoline Lindby, Jeanette Sorensen, Lone Larsen, Malene Rohr Andersen, Ivan Brandslund, Mads Thomassen, Anders GreenAnders Bo Bojesen, Signe Bek Sorensen, Ulla Vogel, Vibeke Andersen, Ann Christina Bergmann, Paal Skytt Andersen, Shaista Rashid, Britta Ornfelt Lund, Britt Kaiser Rasmussen, Sara Avlund, Marie Odum Nielsen, Eva Karolina Nilsdotter Bramstang, Anja Poulsen, Ditte Rudbeck-Resdal, Luise Aamann, Maria Joanna Alexandraki, Ali Foroutani, Line Molzen, Anders Hatrop, Charlotte Siggaard Rittig, Elisabeth Stenbog, Nora Elisabeth Hedback, Rasmus Gaardskaer Nielsen, Frank Vinholt Schiodt, Katrine Carlsen, Ram Benny Dessau, Hans Jurgen Hoffmann, Bjorn Andersen Nexo, Jacob Sode
Dive into the research topics of 'Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease'. Together they form a unique fingerprint.